AQLG delivers concentrated exposure to large-cap growth stocks through HCM's proprietary quantitative model, which aims to identify companies with accelerating fundamentals before the broader market recognizes the trend. The fund targets outperformance during growth-favoring markets while maintaining the liquidity of large-cap holdings.
How It Works
The fund employs HCM's quantitative screening process to identify large-cap stocks exhibiting superior revenue growth, earnings momentum, and improving profit margins relative to sector peers. Holdings are weighted based on growth score strength rather than market cap, creating meaningful overweights in the highest-conviction names. The portfolio typically holds 30-50 positions and rebalances quarterly to capture emerging growth trends while avoiding momentum traps.
Key Features
- Concentrated growth portfolio (30-50 stocks) versus 500+ holdings in typical large-cap funds
- Quantitative model emphasizes earnings acceleration and margin expansion over simple revenue growth
- Active rebalancing captures growth inflection points rather than riding momentum too long
Risks
- Growth stock drawdowns can exceed 40% in rate-rising environments as seen in 2022
- Concentrated portfolio means single stock blowups hurt more — one 20% position decline impacts significantly
- Quantitative models can fail during regime changes when historical growth patterns break down
Who Should Own This
Best suited for investors with 5+ year horizons who want aggressive large-cap exposure without the volatility of small-cap growth funds. Works as a core equity replacement for growth-oriented portfolios or a 10-20% satellite position for balanced investors looking to juice returns. Those uncomfortable with potential 30%+ drawdowns during growth sell-offs should look elsewhere.